Approval · Notice of Compliance 8345 · 2006

FLUCONAZOLE INJECTION: Notice of Compliance 8345

Issued October 24, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 8345
Date: October 24, 2006
Company: Pharmaceutical Partners Of Canada, A Division Of Abraxis Bioscience Inc.
Product type: Prescription Pharmaceutical
Submission: Abbreviated New Drug Submission (ANDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Antifungal agent
Canadian reference product: DIFLUCAN INJECTION (Pfizer Canada Ulc)

Products in this notice

Brand	DIN	Status today
FLUCONAZOLE INJECTION	02248731	Cancelled Pre Market

Medicinal ingredients

FLUCONAZOLE 2 MG per ML